Eylea and Salpingitis tuberculous - from FDA reports


Summary

There is no Salpingitis tuberculous reported by people who take Eylea yet. This review analyzes which people have Salpingitis tuberculous with Eylea. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Eylea and have Salpingitis tuberculous, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 23, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Salpingitis tuberculous when taking Eylea?

Expand the study to include all drugs with the same ingredients

Salpingitis tuberculous and drugs with ingredients of aflibercept.

Expand the study to include reports from both FDA and eHealthMe

Salpingitis tuberculous and Eylea from FDA and eHealthMe reports

Eylea

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. (latest outcomes from Eylea 6,687 users)

Salpingitis Tuberculous

Salpingitis tuberculous (an infection and inflammation in the fallopian tubes with mycobacterium tuburculosis bacteria) has been reported by people with rheumatoid arthritis (latest reports from 3 Salpingitis tuberculous patients).

Browse all side effects of Eylea

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Salpingitis tuberculous

Salpingitis tuberculous

Could your condition cause Salpingitis tuberculous

Salpingitis tuberculous

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Eylea and have Salpingitis tuberculous.

User reviews to the study

More reviews >